Overview

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia

Status:
Completed

Trial end date:
2004-09-01

Target enrollment:

Participant gender:

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. PURPOSE: Clinical trial to study the effectiveness of combination chemotherapy plus peripheral stem cell transplantation in treating patients who have chronic myelogenous leukemia or acute leukemia.

Phase:

Phase 2

Details

Lead Sponsor:

Loyola University

Collaborator:

National Cancer Institute (NCI)

Treatments:

Cyclophosphamide
Cytarabine
Etoposide
Idarubicin
Interferon-alpha
Interferons